- >> Quote Page >>
- >> Company & Fund Search Results >>
- >> Companies A-Z >>
- >> Market News >>
- >> Heatmaps >>
- >> Director Deals >>
- >> Broker Views >>
- >> Market Diary >>
- >> Stock Screener >>
- >> Charts >>
- >> Market Info >>
- >> Fund Centre >>
- >> Fund Screener >>
- >> Fund Details Page >>
- >> Modules - Chart Page >>
- >> Modules - Home Page 'Latest' Panel >>
- >> Modules - Sectors >>
Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC
-
Fri 13 Sep 2019 10:10
Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8200p (from 8000p).
Broker Forecasts data provided by www.sharesmagazine.co.uk
Data provided by 
and 
Prices quoted have a delay of at least 15 minutes. You may receive a different price (which may be higher or lower) when an instruction is executed. Though all reasonable efforts are made to present accurate data, Equiniti Financial Services Limited and third party data providers accept no responsibility for the correctness, completeness or accuracy of the data provided.
Where past performance details are included this is not a reliable indicator of future performance. Short-term past performance of less than one year is a particularly unreliable indicator.
and Prices quoted have a delay of at least 15 minutes. You may receive a different price (which may be higher or lower) when an instruction is executed. Though all reasonable efforts are made to present accurate data, Equiniti Financial Services Limited and third party data providers accept no responsibility for the correctness, completeness or accuracy of the data provided.
Where past performance details are included this is not a reliable indicator of future performance. Short-term past performance of less than one year is a particularly unreliable indicator.